Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Galactose on Permeblity Factor in Patients With FSGS and CKD Stage 5

This study has been withdrawn prior to enrollment.
(Under additional IRB Review)
Sponsor:
Collaborator:
Medical College of Wisconsin
Information provided by (Responsible Party):
Howard Trachtman MD, North Shore Long Island Jewish Health System
ClinicalTrials.gov Identifier:
NCT00816504
First received: December 31, 2008
Last updated: September 3, 2015
Last verified: September 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: December 2009
  Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)